David McGirr
Direktor/Vorstandsmitglied bei INSMED INCORPORATED
Vermögen: 1 Mio $ am 30.04.2024
Aktive Positionen von David McGirr
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
INSMED INCORPORATED | Direktor/Vorstandsmitglied | 30.10.2013 | - |
Independent Dir/Board Member | 30.10.2013 | - | |
RHYTHM PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.11.2015 | - |
Independent Dir/Board Member | 01.11.2015 | - | |
X4 PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.09.2017 | - |
Independent Dir/Board Member | 01.09.2017 | - |
Karriereverlauf von David McGirr
Ehemalige bekannte Positionen von David McGirr
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
VYNE THERAPEUTICS INC. | Direktor/Vorstandsmitglied | 01.01.2017 | 09.03.2020 |
Independent Dir/Board Member | 01.01.2017 | 09.03.2020 | |
SORRENTO TECH INC | Direktor/Vorstandsmitglied | 01.12.2013 | 01.01.2018 |
Independent Dir/Board Member | 01.12.2013 | 01.01.2018 | |
Roka Bioscience, Inc.
Roka Bioscience, Inc. BiotechnologyHealth Technology Roka Bioscience, Inc. is a company that specializes in food safety technology. The company is based in Mendham, NJ and was founded in 2009 by Paul G. Thomas. Roka Bioscience's core technology is their pathogen detection assays which combine the power of target capture, transcription-mediated amplification, and hybridization protection assay to target ribosomal RNA (rRNA), an optimal target for molecular technology in food pathogen detection applications. The company offers a range of products including the Atlas® System and various detection assays for E. coli, Listeria, Salmonella, Campylobacter, and Legionella. Roka Bioscience also provides environmental testing solutions and technical support for their customers. Mary Duseau has been the CEO of the company since 2015. | Direktor/Vorstandsmitglied | - | 01.01.2018 |
RELYPSA INC | Direktor/Vorstandsmitglied | 01.01.2013 | 01.09.2016 |
Independent Dir/Board Member | 01.01.2013 | 01.09.2016 | |
CUBIST PHARMACEUTICALS INC | Vorstandsvorsitzender | 01.03.2013 | 01.06.2014 |
Finanzdirektor/CFO | 01.11.2002 | 01.03.2013 | |
Treasurer | 01.11.2002 | 01.01.2003 | |
LifeCell Corp.
LifeCell Corp. BiotechnologyHealth Technology LifeCell Corp. develops and markets tissue repair products. The firm focuses on reconstructive, urogynecologic and orthopedic surgical procedures. Its products include alloderm, strattice, graft jacket, allocraftdbm and repliform. The company was founded in 1986 and is headquartered in Branchburg, NJ. | Direktor/Vorstandsmitglied | 12.11.2007 | 19.05.2008 |
░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░ ░░░░░░ ░░░░░ ░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░ ░░░░░░░ ░ ░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░ ░░░░░░░ ░░░░░ ░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Ausbildung von David McGirr
University of Glasgow | Undergraduate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 15 |
Vereinigtes Königreich | 3 |
Operativ
Director/Board Member | 10 |
Independent Dir/Board Member | 7 |
Director of Finance/CFO | 3 |
Sektoral
Health Technology | 11 |
Finance | 4 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
INSMED INCORPORATED | Health Technology |
RHYTHM PHARMACEUTICALS, INC. | Health Technology |
X4 PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 11 |
---|---|
LifeCell Corp.
LifeCell Corp. BiotechnologyHealth Technology LifeCell Corp. develops and markets tissue repair products. The firm focuses on reconstructive, urogynecologic and orthopedic surgical procedures. Its products include alloderm, strattice, graft jacket, allocraftdbm and repliform. The company was founded in 1986 and is headquartered in Branchburg, NJ. | Health Technology |
Cubist Pharmaceuticals LLC
Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
Sorrento Tech, Inc.
Sorrento Tech, Inc. Medical SpecialtiesHealth Technology Sorrento Tech, Inc., also known as Roka Bio Science, is a private company that specializes in food safety technology. The company is based in Warren, NJ and has subsidiaries in the United States. The company's core technology is the Roka pathogen detection assays, which combine the power of target capture, transcription-mediated amplification, and hybridization protection assay to deliver a fully automated, single-protocol assay with reduced enrichment times and superior sensitivity. The company's products include the Atlas® system and various detection assays for E. coli, Listeria, Salmonella, Campylobacter, and Legionella. Roka Bio Science provides solutions for the beef, dairy, pet food, poultry, produce, ready-to-eat foods, spices and ingredients, and environmental testing industries. Roka Bio Science was founded in 2009 by Paul G. Thomas. | Health Technology |
Arsanis, Inc.
Arsanis, Inc. BiotechnologyHealth Technology Arsanis, Inc. operates as a clinical-stage biotechnology company, which engages in provision of monoclonal antibody immunotherapies to address serious infectious diseases. The company was founded by Eszter Nagy, Tillman U. Gerngross, and Errik B. Anderson on August 2, 2010 and is headquartered in Waltham, MA. | Health Technology |
Menlo Therapeutics, Inc.
Menlo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Menlo Therapeutics Inc. operates as biopharmaceutical company which is focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with dermatologic conditions such as atopic dermatitis, psoriasis and prurigo nodularis. The company was founded by Ed F. Schnipper in October, 2011 and is headquartered in Bridgewater, CA. | Health Technology |
S.G. Warburg Group Plc
S.G. Warburg Group Plc Investment Banks/BrokersFinance S.G. Warburg Group Plc provides investment banking services. The company is focusing on mergers and acquisitions. It was founded in 1934 and is headquartered in London, the United Kingdom. | Finance |
GAB Robins North America, Inc.
GAB Robins North America, Inc. Insurance Brokers/ServicesFinance GAB Robins North America, Inc. provides insurance claim services. It offers administration services to property & casualty insurance companies and self-insured organizations. The firm also offers third-party insurance fund administration and other insurance related services in 52 countries around the world. GAB Robins North America was founded in 1932 and is headquartered in Parsippany, NJ. | Finance |
Relypsa, Inc.
Relypsa, Inc. Pharmaceuticals: MajorHealth Technology Relypsa, Inc. operates as a bio-pharmaceutical company, which engages in the development and commercialization of late-stage medicines in the iron deficiency, nephrology, and cardio-renal therapeutic areas. It offers Veltassa, a potassium binder approved for the treatment of hyperkalemia. The company was founded by Jerry M. Buysse, Gerrit Klaerner, Michael Burdick, Jay P. Shepard, Detlef F. Albrecht, George Tyson, Sandra I. Coufal and Vic Ciaravino on October 29, 2007 and is headquartered in Redwood City, CA. | Health Technology |
Hippo, Inc.
Hippo, Inc. Internet RetailRetail Trade Hippo, Inc. is an online retailer that specializes in selling bellman carts and waste receptacles. | Retail Trade |
S.G. Warburg & Co., Inc. | Finance |
Roka Bioscience, Inc.
Roka Bioscience, Inc. BiotechnologyHealth Technology Roka Bioscience, Inc. is a company that specializes in food safety technology. The company is based in Mendham, NJ and was founded in 2009 by Paul G. Thomas. Roka Bioscience's core technology is their pathogen detection assays which combine the power of target capture, transcription-mediated amplification, and hybridization protection assay to target ribosomal RNA (rRNA), an optimal target for molecular technology in food pathogen detection applications. The company offers a range of products including the Atlas® System and various detection assays for E. coli, Listeria, Salmonella, Campylobacter, and Legionella. Roka Bioscience also provides environmental testing solutions and technical support for their customers. Mary Duseau has been the CEO of the company since 2015. | Health Technology |
- Börse
- Insiders
- David McGirr
- Erfahrung